New frontiers in cardiovascular behavioral medicine: Comparative effectiveness of exercise and medication in treating depression

Cleveland Clinic Journal of Medicine

Volumn 78, Issue SUPPL. 1, 2011, Pages

  Blumenthal, James A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; BEHAVIORAL MEDICINE; CARDIOVASCULAR DISEASE; DEPRESSION; HEART FAILURE; HUMAN; KINESIOTHERAPY; PROGNOSIS; PSYCHOLOGICAL ASPECT; RISK FACTOR; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BEHAVIORAL MEDICINE; CARDIOVASCULAR DISEASES; DEPRESSION; EXERCISE THERAPY; HEART FAILURE; HUMANS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84856794945     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.78.s1.06     Document Type: Article

References (95)

1. Blumenthal JA, Califf R, Williams RS, Hindman M. Cardiac rehabilitation: a new frontier for behavioral medicine. J Cardiac Rehabil 1983; 3:637-656.
2. Lewis T. Diseases of the Heart. New York: Macmillan; 1933:41-49.
3. Levine SA, Lown B. The "chair" treatment of acute thrombosis. Trans Assoc Am Physicians 1951; 64:316-327.
4. Cain HD, Frasher WG, Stivelman R. Graded activity program for safe return to self-care after myocardial infarction. JAMA 1961; 177:111-115.
5. Hellerstein HK, Ford AB. Rehabilitation of the cardiac patient. JAMA 1957; 14:225-231.
6. Naughton J, Bruhn JG, Lategola MT. Effects of physical training on physiologic and behavioral characteristics of cardiac patients. Arch Phys Med Rehabil 1968; 49:131-137.
7. O'Connor GT, Buring JE, Yusuf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 80:234-244.
8. Wenger NK, Froelicher ES, Smith LK, et al. Cardiac rehabilitation: clinical practice guideline no. 17. Rockville, MD: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, National Heart, Lung, and Blood Institute; October 1995; AHCPR publication 96-0672.
9. Blumenthal JA, Emery CF, Cox DR, et al. Exercise training in healthy type A middle-aged men: effects on behavioral and cardiovascular responses. Psychosom Med 1988; 50:418-433.
10. Schuler G, Schlierf G, Wirth A, et al. Low-fat diet and regular, supervised physical exercise in patients with symptomatic coronary artery disease: reduction of stress-induced myocardial ischemia. Circulation 1988;77:172-181.
11. Jiang W, Trauner MA, Coleman RE, et al. Association of physical fitness and transient myocardial ischemia in patients with coronary artery disease. J Cardiopulm Rehabil 1995; 15:431-438.
12. Blumenthal JA, Jiang W, Babyak MA, et al. Stress management and exercise training in cardiac patients with myocardial ischemia: effects on prognosis and evaluation of mechanisms. Arch Int Med 1997; 157:2213-2223.
13. Oldridge NB, Guyatt GH, Fisher ME, Rimm AA. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA 1988; 260:945-950.
14. Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2001:CD001800.
15. Folkins CH, Sime WE. Physical fitness training and mental health. Am Psychol 1981; 36:373-389.
16. Hughes JR. Psychological effects of habitual aerobic exercise: a critical review. Prev Med 1984; 13:66-78.
17. Plante TG, Rodin J. Physical fitness and enhanced psychological health. Curr Psychol: Res Rev 1990; 9:3-24.
18. Review Panel on Coronary-Prone Behavior and Coronary Heart Disease. Coronary-prone behavior and coronary heart disease: a critical review. Circulation 1981; 63:1199-1215.
19. Smith TW. Hostility and health: current status of a psychosomatic hypothesis. Health Psychol 1992; 11:139-150.
20. Lett HS, Blumenthal JA, Babyak MA, Strauman TJ, Robins C, Sherwood A. Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med 2005; 67:869-878.
21. Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004; 66:305-315.
22. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a metaanalysis. Psychosom Med 2004; 66:802-813.
23. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCR-R). JAMA 2003; 289:3095-3105.
24. Belsher G, Costello CG. Relapse after recovery from unipolar depression: a critical review. Psychol Bull 1988; 104:84-96.
25. Strothers HS III, Rust G, Minor P, Fresh E, Druss B, Satcher D. Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression. J Am Geriatr Soc 2005; 53:456-461.
26. Simpson SM, Krishnan LL, Kunik ME, Ruiz P. Racial disparities in diagnosis and treatment of depression: a literature review. Psychiatr Q 2007; 78:3-14.
27. Sclar DA, Robison LM, Skaer TL. Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States. Int Clin Psychopharmacol 2008; 23:106-109.
28. Waldman SV, Blumenthal JA, Babyak MA, et al. Ethnic differences in the treatment of depression in patients with ischemic heart disease. Am Heart J 2009; 57:77-83.
29. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988; 50:627-633.
30. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149:1785-1789.
31. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270:1819-1825.
32. Gonzalez MB, Snyderman TB, Colket JT, et al. Depression in patients with coronary artery disease. Depression 1996; 4:57-62.
33. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 2001; 358:1766-1771.
34. Burker EJ, Blumenthal JA, Feldman M, et al. Depression in male and female patients undergoing cardiac surgery. Br J Clin Psychol 1995; 34(Pt 1):119-128.
35. Lespérance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000; 160:1354-1360.
36. Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91:999-1005.
37. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78:613-617.
38. Burg MM, Benedetto C, Soufer R. Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med 2003; 65:508-510.
39. Blumenthal JA, Lett HS, Babyak MA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003; 362:604-609.
40. Connerney I, Sloan RP, Shapiro PA, Bagiella E, Seckman C. Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med 2010; 72:874-881.
41. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure: a meta analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006; 48:1527-1537.
42. Murberg TA, Furze G. Depressive symptoms and mortality in patients with congestive heart failure: a six-year follow-up study. Med Sci Monit 2004; 10:CR643-CR648.
43. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161:1849-1856.
44. Sherwood A, Blumenthal JA, Trivedi R, et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Int Med 2007; 167:367-373.
45. Frasure-Smith N, Lespérance F, Habra M, et al. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fi brillation and heart failure. Circulation 2009; 120:134-140.
46. Sherwood A, Blumenthal JA, Hinderliter AL, et al. Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol 2011; 57:418-423.
47. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a metaanalysis. Diabetes Care 2001; 24:1069-1078.
48. Thakore JH, Richards PJ, Reznek RH, Martin A, Dinan TG. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry 1997; 41:1140-1142.
49. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996; 153:1313-1317.
50. Delgado PL, Moreno FA. Role of norepinephrine in depression. J Clin Psychiatry 2000; 61 (suppl 1):5-12.
51. Akil H, Haskett RF, Young EA, et al. Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and betaendorphin. Biol Psychiatry 1993; 33:73-85.
52. Kop WJ, Gottdiener JS, Tangen CM, et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002; 89:419-424.
53. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995; 14:88-90.
54. Lehto S, Koukkunen H, Hintikka J, Viinamäki H, Laakso M, Pyörälä K. Depression after coronary heart disease events. Scand Cardiovasc J 2000; 34:580-583.
55. Camacho TC, Roberts RE, Lazarus NB, Kaplan GA, Cohen RD. Physical activity and depression: evidence from the Alameda County Study. Am J Epidemiol 1991; 134:220-231.
56. Clinical Practice Guideline Number 5: Depression in Primary Care, 2: Treatment of Major Depression. Rockville, MD: U.S. Department of Health and Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551.
57. Anderson IM, Ferrier IN, Baldwin RC, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008; 22:343-396.
58. American Psyciatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157 (suppl 4):1-45.
59. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a metaanalysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5:e45.
60. Hansen R, Gaynes B, Thieda P, et al. Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatr Serv 2008; 59:1121-1129.
61. Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med 2005; 143:415-426.
62. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longerterm outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163:1905-1917.
63. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. JAMA 2002; 287:203-209.
64. Marcus SC, Olfson M. National trends in the treatment of depression from 1998 to 2007. Arch Gen Psychiatry 2010; 67:1265-1273.
65. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289:3106-3116.
66. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005; 62:792-798.
67. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701-709.
68. Serebruany VL, Glassman AH, Malinin AI, et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 2003; 108:939-44.
69. O'Connor CM, Jiang W, Kuchibhatla M, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010; 56:692-699.
70. Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004; 66:466-474.
71. Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial. JAMA 2007; 297:367-379.
72. Salzman C, Schneider L, Alexopoulos GS. Pharmacological treatment of depression in late life. In: Bloon F, Kupfer D, eds. Psychopharmacology: Fourth Generation of Progress. New York: Raven Press; 1995.
73. Franklin BA, Bonzheim K, Gordon S, Timmis GC. Safety of medically supervised outpatient cardiac rehabilitation exercise therapy: a 16-year follow-up. Chest 1998; 114:902-906.
74. Vongvanich P, Paul-Labrador MJ, Merz CN. Safety of medically supervised exercise in a cardiac rehabilitation center. Am J Cardiol 1996; 77:1383-1385.
75. O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: H-F ACTION randomized controlled trial. JAMA 2009; 301:1439-1540.
76. Milani RV, Lavie CJ, Cassidy MM. Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J 1996; 132:726-732.
77. Beniamini Y, Rubenstein JJ, Zaichkowsky LD, Crim MC. Effects of high-intensity strength training on quality-of-life parameters in cardiac rehabilitation patients. Am J Cardiol 1997; 80:841-846.
78. Maines TY, Lavie CJ, Milani RV, Cassidy MM, Gilliland YE, Murgo JP. Effects of cardiac rehabilitation and exercise programs on exercise capacity, coronary risk factors, behavior, and quality of life in patients with coronary artery disease. South Med J 1997; 90:43-49.
79. Milani RV, Lavie CJ. Prevalence and effects of cardiac rehabilitation on depression in the elderly with coronary heart disease. Am J Cardiol 1998; 81:1233-1236.
80. Blumenthal JA, Emery CF, Rejeski WJ. The effects of exercise training on psychosocial functioning after myocardial infarction. J Cardiopulmonary Rehabil 1988; 8:183-193.
81. Taylor CB, Houston-Miller N, Ahn DK, Haskell W, DeBusk RF. The effects of exercise training programs on psychosocial improvement in uncomplicated postmyocardial infarction patients. J Psychosom Res 1986; 30:581-587.
82. Stern MJ, Gorman PA, Kaslow L. The group counseling v exercise therapy study: a controlled intervention with subjects following myocardial infarction. Arch Intern Med 1983; 143:1719-1725.
83. Brosse AL, Sheets ES, Lett HS, Blumenthal JA. Exercise and the treatment of clinical depression in adults: recent fi ndings and future directions. Sports Med 2002; 32:741-760.
84. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ 2001; 322:763-767.
85. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst Rev 2009:CD004366.
86. Blumenthal JA, Babyak MA, Carney RM, et al. Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc 2004; 36:746-755.
87. Eden J, Wheatley B, McNeil B, Sox H, eds. Institute of Medicine. Knowing What Works in Health Care. A Roadmap for the Nation. Washington DC: National Academics Press; 2009.
88. Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med 2009; 151:203-205.
89. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373:1190-1197.
90. Blumenthal JA, Babyak MA, Moore KA, et al. Effects of exercise training on older patients with major depression. Arch Intern Med 1999; 159:2349-2356.
91. Babyak M, Blumenthal JA, Herman S. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med 2000; 62:633-638.
92. Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 2007; 69:587-596.
93. Hoffman B, Babyak M, Craighead WE, et al. Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study. Psychosom Med 2010; 73:127-133.
94. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med 2005; 28:1-8.
95. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008; 118:1768-1775.